End-to-End CDMO Bend operates three U.S. facilities in Bend, Oregon; Clearwater, Florida; and Gainesville, Georgia, enabling geographic flexibility and risk mitigation for development and manufacturing programs. It offers end-to-end services from preclinical to commercial, including solubility enhancement, spray-dried dispersion and particle engineering, oral solid dose and multiparticulate formulation development, analytical development and quality control, GMP manufacturing, tech transfer and commercial readiness. This positions Bend as a one-stop partner for biotech and pharma seeking streamlined scale-up, rapid regulatory filings, and a smooth transition to commercial manufacturing.

Specialized Formulations Core strengths in solubility enhancement and advanced drug delivery—such as spray-dried dispersion and particle engineering—plus oral solid dose and multiparticulate development for immediate and modified-release products. These capabilities attract programs with solubility challenges or complex dosing needs, creating opportunities to expand engagements from early-stage development through late-stage manufacturing.

Collaborations & Delivery Notable collaboration with Starton Therapeutics to optimize the STAR-LLD oral lenalidomide tablet demonstrates Bend's ability to support continuous delivery platforms and technically demanding dosage forms. This track record highlights Bend's potential as a partner for other companies pursuing innovative delivery technologies, co-development, scale-up, and regulatory-ready manufacturing.

Capacity & Growth Active capacity expansion and workforce development signal Bend's commitment to scaling for larger late-stage and commercial programs. Investments in the Gainesville facility and plans for a new apprenticeship program indicate readiness to absorb higher volumes and broaden the U.S. life sciences ecosystem, offering customers secure capacity and continuity.

Regulatory Leadership Strategic leadership and regulatory readiness are emphasized through the appointment of a seasoned chief scientific officer and strong focus on analytical development, quality control, and regulatory compliance. Bend's capabilities in tech transfer and commercial readiness provide a credible partner to navigate filings, audits, and successful transitions to commercial manufacturing.